Prelude Therapeutics Incorporated · NASDAQ:PRLD
Vaddi Krishna reported a 13.15% stake in Prelude Therapeutics Incorporated (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Vaddi Krishna reported a 13.15% stake in Prelude Therapeutics Incorporated, 6,745,647 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 13.15%
- Shares
- 6,745,647
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vaddi Krishna | 13.15% | 6,745,647 |
Source
Related
- Prelude Therapeutics Incorporated
- Vaddi Krishna
- Prelude Therapeutics Incorporated shareholders
- Schedule 13G/A · Vaddi Krishna · May 15, 2025
- Schedule 13G/A · Vaddi Krishna · Feb 14, 2025
- Schedule 13G · Soleus Capital Management, L.P. · Jul 8, 2026
- Form 4 · Shah Rajeev M. · Apr 28, 2026
- Schedule 13G · Ra Capital Management, L.P. · Apr 28, 2026
- Form 4 · Bonita David P · Apr 23, 2026
- Form 4 · OrbiMed Genesis GP LLC · Apr 23, 2026